Structure-activity relationship of biaryl acylsulfonamide analogues on the human EP3 prostanoid receptor

被引：38

作者：

Gallant, M ^{[1
]}

Carrière, MC ^{[1
]}

Chateauneuf, A ^{[1
]}

Denis, D ^{[1
]}

Gareau, Y ^{[1
]}

Godbout, C ^{[1
]}

Greig, G ^{[1
]}

Juteau, H ^{[1
]}

Lachance, N ^{[1
]}

Lacombe, P ^{[1
]}

Lamontagne, S ^{[1
]}

Metters, KM ^{[1
]}

Rochette, C ^{[1
]}

Ruel, R ^{[1
]}

Slipetz, D ^{[1
]}

Sawyer, N ^{[1
]}

Tremblay, N ^{[1
]}

Labelle, M ^{[1
]}

机构：

[1] Merck Frosst Ctr Therapeut Res, Pointe Claire, PQ H9R 4P8, Canada

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2002年 / 12卷 / 18期

关键词：

D O I：

10.1016/S0960-894X(02)00518-8

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Potent and selective ligands for the human EP3 prostanoid receptor are described. Biaryl compounds hearing a tethered ortho substituted acidic moiety were identified as potent EP3 antagonists based on the SAR described herein. The binding affinity of key compounds on all eight human prostanoid receptors is reported. (C) 2002 Elsevier Science Ltd. All rights reserved.

引用

页码：2583 / 2586

页数：4

共 50 条

[31] Study of the structure-activity relationship of polymyxin analogues
Kinoshita, Yuhei
Yakushiji, Fumika
Matsui, Hidehito
Hanaki, Hideaki
Ichikawa, Satoshi
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (16) : 2713 - 2716
[32] CLONING AND EXPRESSION OF 3 ISOFORMS OF THE HUMAN EP(3) PROSTANOID RECEPTOR
ADAM, M
BOIE, Y
RUSHMORE, TH
MULLER, G
BASTIEN, L
MCKEE, KT
METTERS, KM
ABRAMOVITZ, M
FEBS LETTERS, 1994, 338 (02) : 170 - 174
[33] Role of E-type prostaglandin receptor EP3 in the vasoconstrictor activity evoked by prostacyclin in thromboxane-prostanoid receptor deficient mice
Li, Zhenhua
Zhang, Yingzhan
Liu, Bin
Luo, Wenhong
Li, Hui
Zhou, Yingbi
SCIENTIFIC REPORTS, 2017, 7
[34] Structure-activity relationship of antileishmanials neolignan analogues
Aveniente, Mario
Pinto, Eduardo F.
Santos, Lourivaldo S.
Rossi-Bergmann, Bartira
Barata, Lauro E. S.
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (23) : 7337 - 7343
[35] Structure-activity relationship studies of curcumin analogues
Fuchs, James R.
Pandit, Bulbul
Bhasin, Deepak
Etter, Jonathan P.
Regan, Nicholas
Abdelhamid, Dalia
Li, Chenglong
Lin, Jiayuh
Li, Pui-Kai
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (07) : 2065 - 2069
[36] Structure-activity relationship analysis of a series of nonsteroidal analogues as androgen receptor antagonists
Yuan, Miao
Cheng, Ping
Zhang, Shuping
NEW JOURNAL OF CHEMISTRY, 2021, 45 (03) : 1176 - 1186
[37] Structure-Activity Relationship and Bioactivity of Short Analogues of ELABELA as Agonists of the Apelin Receptor
Tran, Kien
Murza, Alexandre
Sainsily, Xavier
Delile, Eugenie
Couvineau, Pierre
Cote, Jerome
Coquerel, David
Peloquin, Maude
Auger-Messier, Mannix
Bouvier, Michel
Lesur, Olivier
Sarret, Philippe
Marsault, Eric
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (01) : 602 - 615
[38] Role of E-type prostaglandin receptor EP3 in the vasoconstrictor activity evoked by prostacyclin in thromboxane-prostanoid receptor deficient mice
Zhenhua Li
Yingzhan Zhang
Bin Liu
Wenhong Luo
Hui Li
Yingbi Zhou
Scientific Reports, 7
[39] HUMAN EP3 RECEPTOR VARIANTS DIFFER AT THEIR CARBOXYL TERMINI
KEDZIE, KM
BAILEY, TJ
DONELLO, JE
FAIRBAIRN, CE
GIL, DW
PIERCE, K
BOGARDUS, AM
WOODWARD, DF
REGAN, JW
FASEB JOURNAL, 1994, 8 (07): : A1386 - A1386
[40] EP3 prostanoid receptor isoforms utilize distinct mechanisms to regulate ERK 1/2 activation
Israel, Davelene D.
Regan, John W.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2009, 1791 (04): : 238 - 245

← 1 2 3 4 5 →